Key facts
- This page summarizes Srinivas Akkaraju's Form 4 filing for Jiya Acquisition Corp..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Sep 2022, 18:39.
Srinivas Akkaraju - 23 Sep 2022 Form 4 Insider Report for Jiya Acquisition Corp.
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 23 Sep 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Sep 2022, 18:39:55 UTC
- Prior SEC filing
- 20 Apr 2023
- Next SEC filing
- 13 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Srinivas Akkaraju
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Srinivas Akkaraju filed Form 4 for Jiya Acquisition Corp. on 23 Sep 2022.
Change
- Previous filing in this sequence was filed on 20 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JYAC
transaction
Derivative
Class B Common Stock
Other
- Transaction value
- Shares
- +29,667
- Change %
- +1.2%
- Price
- Shares after
- 2,437,114
- Date
- 23 Sep 2022
- Ownership
- See Footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 29,667
- Exercise price
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares of Class B Common Stock of the Issuer ("Class B Shares") will automatically convert into shares of Class A Common Stock of the Issuer ("Class A Shares") on a one-for-one basis (subject to certain adjustments for stock splits, stock dividends, reorganizations, recapitalizations and similar transactions) concurrently with or immediately following the consummation of the Issuer's initial business combination, as described in the section entitled "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-249808) filed with the Securities and Exchange Commission on November 16, 2020. The Class B Shares have no expiration date.
Footnote F2
Reflects the forfeiture of Class B Shares held by an employee of the Issuer upon such employee's resignation from the Issuer. As a result, these Class B Shares were automatically returned to Jiya Holding Company LLC ("Jiya Holdco") for no consideration ($0).
Footnote F3
Reflects the Class B Shares held by Jiya Holdco. This amount does not reflect the 30,000 Class B shares directly held by Dr. Srinivas Akkaraju M.D., Ph.D.
Footnote F4
Jiya HoldCo is wholly owned by Samsara BioCapital, L.P. ("Samsara LP"). Dr. Akkaraju has voting and dispositive control over the reported securities held by Jiya Holdco via Dr. Akkaraju's control of Samsara LP's general partner, Samsara BioCapital GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein.